Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)
NCT01884350
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1217
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-valvular Atrial Fibrillation
Interventions
DRUG:
Apixaban
Sponsor
Bristol-Myers Squibb